at CMEF 2015

Welcome
Introductions
Contents
M a y 15 -1 8 , 2 015
National Exhibition and
Convention Center, Shanghai, China
Isr ael Pavilion , Hal l 6 – 2F
Profiles
at CMEF
DIVERSITY is the backbone of Israel’s Medical Device Industry:
Diverse Companies - Diverse Technological Implementation - Diverse Medical Applications.
Welcome
Why Israel?
By the end of the 1990s, Israel was home to more than 200 life science companies. With
steady growth over the last decade (some 40 new companies formed each year), Israel has
introduced creativity and innovation into the field; today there are over 1200 active life
science companies.
The Largest Sector is Medical Devices and HealthCare IT Technologies (more than 60 percent
of companies). In the medical device arena, Israeli scientists and engineers have integrated
advanced technologies in electronics, communications and electro-optics to develop worldclass innovations in Digital Imaging, Medical Lasers, Telemedicine, Early Diagnostic and Smart
Surgical equipment and more. More than 500 medical device exporters are engaged in a
variety of medical applications such as Cardiovascular and Peripheral Vascular, Neurology
and Degenerative Disease, Emergency Medicine, Intensive Care and Rehabilitation, Respiratory
and Airway Management, Oncology, Women’s’ Health, Orthopedics and Sport Medicine,
Gastrointestinal, Infection Control, Ophthalmology, Pain and Wound Management, Oral and
Dental, Dermatology and Aesthetics.
Contents
There is no other country in the world with such a concentration of life science companies.
Companies rooted in top international academic and research institutions; staffed by highly
educated and skilled teams; operating within an entrepreneurial and audacious climate, to
offer a variety of innovative medical solutions and technologies that answer today’s healthcare
challenges: to lower overall healthcare costs and meet the world’s evolving needs of aging
populations while creating significant investor value.
Introductions
In a relatively short period of time, an impressive 34 per cent of these companies are already
generating revenues. Israel’s entrepreneurial ecosystem creates opportunities for start-ups to
become advanced, commercially viable and promising businesses. As proof of the industry’s
development, 2013 life science exports reached $8 billion, growing steadily since 2008;
while a rich pipeline of seed companies promises to perpetuate current growth.
Profiles
2
The IEICI’s Life Science Department is the leader in business matching between
the more than 1,200 companies in the Israeli life science industry and worldwide
business partners at all levels. It has a proven ability to identify and match suitable
potential business partners, organize one-on-one business meetings, and is a
focal point for contacts with the government as well as with industry.
The IEICI is the major organizer of Israeli company participation at CMEF 2015.
Discover Israeli Life Science Industry with IEICI.
Introductions
The Israel Export & International Cooperation Institute, supported by member
firms, private sector bodies and the government of Israel, advances business
relationships between Israeli exporters and overseas businesses and organizations.
By providing a wide range of export-oriented services to Israeli companies and
complementary services to the international business community, the Institute
helps build successful joint ventures, strategic alliances and trade partnerships.
Welcome
at CMEF 2015
Ms. Angela W. Rabinovich, Manager, Life Sciences
Tel: +972 (3) 5142891 | E-mail: [email protected]
Tel: +972-(3)-5142866
| E-mail: [email protected]
Contents
Ms. Peggy Mizrahi, Manager, China Unit
Profiles
3
To facilitate the access to this growing pool of innovation, Israel's Ministry of Economy
has 4 offices in Beijing, Shanghai, Guangzhou and Hong-Kong. These offices are there to
assist Chinese and Israeli companies in creating business opportunities and long-lasting
commercial relations. Our teams are here to accompany and support Israeli exporters in
their activities in China, promote investments in Israel and stimulate strategic cooperation
between partners from both countries.
We invite Chinese companies and entities seeking Israeli technologies, investment
opportunities and R&D collaborations to approach us. We can also assist in identifying
adequate solutions and partners in Israel, in connecting with potential collaborators, and
as cases may be, help in your visit to Israel.
Introductions
Israel is well known for its innovation and inventiveness with thousands of companies in
various technological sectors, including the medical devices industry. Despite the unfavorable
global economic climate the medical devices sector in Israel has been growing steadily with
nearly 700 medical device outfits, and the leading country with medical device patents per
capita. The investment ecosystem is well developed, and the venture capital investments
are on the rise in both dollars and deals.
Welcome
Israeli Ministry of Economy and Trade &
Economic Missions to China
For further information, please visit our web-site: www.itrade.gov.il/china or contact us
directly:
Mr. Chaim Martin
Head of Economic Office, Embassy of Israel
Tel: +86 10 8532 0664
E-mail: [email protected]
Shanghai
Contents
Beijing
Mr. Elad Gafni
Consul, Head of Economic and Trade Mission to East China, Consulate General of Israel
Tel: + 86 21 6010 2507/8
E-mail: [email protected]
Guangzhou
Profiles
Ms. Noa Heinemann
Consul, Head of Economic and Trade Mission to South China
Consulate General of Israel, Guangzhou
Tel: +86 20 8513 0518/9
E-mail: [email protected]
Hong-Kong
Mr. Elad Goz
Consul, Head of Economic and Trade Mission
Consulate General of Israel
Tel: +85 2 2821 7509
E-mail: [email protected]
4
CMEF 2015 Index
Company name
Categories Classification
1.
ArTack Medical
Medical Devices
Medical Equipment
Disposable & Implantable
MIS - Minimally Invasive System
Page No.
7
General Surgery
Regulatory Approval
2.
Babysense
Medical Devices
Monitoring
8
BioLight
Medical Devices
Medical Equipment
OTC – Over the Counter
9
ENT - Ear Nose & Throat
Allergy
Initial Revenues
4.
Cnoga
Medical Devices
Diagnostic & Monitoring
Telemedicine
10
Introductions
Respiratory
Revenue Growth
3.
Welcome
No.
Diabetes, Endocrinology, Cardiovascular
Initial Revenues
EasyNotes Medical
Medical Devices
MIS - Minimally Invasive System
11
Diabetes, Metabolic Surgery
Clinical trials
6.
IceCure Medical
Medical Devices
MIS - Minimally Invasive System
12
Contents
5.
Women's Health, Oncology
Initial Revenues
7.
LevEl
13
Cardiovascular, General Health
Initial Revenues
8.
Medisim Ltd.
Medical Devices
Diagnostic
14
Profiles
Medical Devices
Healthcare IT, Telemedicine
Diagnostic & Monitoring
General Health
Revenue Growth
5
Company name
Categories Classification
Page No.
9.
MediTouch
Medical Devices
Medical Services
Medical Equipment
Monitoring, Telemedicine
Neurology & Degenerative Disease
Orthopedic, Pediatrics, Rehabilitation
Revenue Growth
15
10.
Persys Medical /
First Care
Medical Devices
Medical Equipment, Drug Delivery
16
11.
Shekel Scales
Medical Devices
Healthcare IT
Others (Industrial use / OEM)
Medical Equipment, Telemedicine, EHR
Hospital Units/Clinics, SW and HW
17
General Health
Revenue Growth
12.
Simbionix
Medical Devices
Training
18
13.
SonicBone Medical
Medical Devices
Diagnostic
19
Contents
Cardiovascular, Dental, Emergency Medicine,
Gastrointestinal, General Surgery, Gynecology,
Internal Medicine, Obesity, Obstetrics, Oral
Care, Orthopedic, Prenatal, Primary Care,
Pulmonary, Respiratory, Urology, Women’s
Health
Revenue Growth
Introductions
Emergency Medicine
Revenue Growth
Welcome
No.
Pediatrics, Endocrinology, Primary Care
Regulatory Approval, Initial Revenues
14.
STI Laser
20
Cardiovascular, Gastrointestinal, Orthopedic
Revenue Growth
15.
TavTech
Medical Devices
Drug Delivery
MIS - Minimally Invasive System
21
Profiles
Medical Devices
Disposable & Implantable
MIS - Minimally Invasive Systems
Dermatology & Aesthetics
Gastrointestinal, Wound management
Revenue Growth
6
www.artack-medical.com
Company at a Glance:
‫ ‏‬rTack Medical is a privately held medical device company developing a variety of tools for the
A
multi-billion dollar minimally invasive surgery market. The tools are based on the Company’s
patented Drive Platform, which allows the delivery of torque through a 5-mm articulated shaft.
Category, Sub-category & Therapeutic Area(s):
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Medical Devices
Disposable & Implantable, MIS - Minimally Invasive System
Medical Equipment
General Surgery
Regulatory Approval
Introductions
‫ ‏‬rTack Medical's first device is the eTack™ for Hernia Mesh Fixation. The eTack offers a
A
comprehensive solution, aiming to set a new standard and revolutionize the technique of
hernia mesh fixation without changing the basic clinical approach of the surgery. The eTack
is a unique and smart, Motorized & Articulated Tacker for Hernia Mesh Fixation, by which it
aims to tackle the major drawbacks of the traditional surgical procedure and be part of the
global trends of converting the most conservative surgeon from manual to motorized devices.
The Company's solutions are aligned with the accelerating demand for minimally invasive
surgical procedures and are integrated with the upcoming surgery robotics solutions.
Welcome
ArTack Medical Ltd.
Technology & Product(s):
The eTack is a novel, revolutionary motorized articulated laparoscopic fixation device. The
eTack includes an “In-line" Motorized Handle, an Articulated shaft and an Exchangeable
Cartridge (10-30 tacks per cartridge). It is designed for the laparoscopic repair as well as
for the open approached surgeries and can be used with any current available mesh.
Contents
In order to overcome today's most common laparoscopic hernia mesh fixation technique
drawbacks, such as a time consuming, cumbersome and demanding procedure, and in order
to align with the new demand for low cost minimal invasive procedure, ArTack Medical is
developing an articulated and motorized device, which does not require any change in
current surgery flow. It is a simple and automated device that requires a short learning curve
and delivers consistent results. ArTack Medical is aiming to approach both laparoscopic and
open surgery approaches.
The eTack enables one handed tacking, provides rigid and precise articulation, and maintains
existing mechanism and materials. The device is easy for new users, provides better visualization,
and enables easier access and maneuverability to the surgeon (no need to cross the table to
fixate a mesh). In addition, utilization of the device requires less trocars, and therefore will
require less cuts and incisions resulting in better cosmetic outcomes to the patient.
Objectives:
Target Businesses:
Target Countries:
To establish an eco system for a successful business activity
Distributors, Manufacturers, Investors, Strategic Partners
China, India, Japan, South Korea, Singapore, Hong-Kong
Profiles
Goals:
7
www.babysense.co.il
Company at a Glance:
Privately held, medical device company active in development, manufacturing and marketing
of health monitoring baby products. The company is active in detection and prevention of
sudden infant death syndrome (SIDS) being the leading cause of death in basically healthy
infants up to one year of age.
Welcome
Babysense
Company’s products meet the stringent requirements and needs of the institutional and
private sectors and are used by parents and hospitals around the world.
The Company is present in over 35 countries through its subsidiaries and exclusive international
distributors.
With over 24 years of experience in baby products and numerous successful patents, we
constantly seek new ways to make parenting easier and safer.
Category, Sub-category & Therapeutic Area(s):
Category:
Medical Devices
Sub-category:
Monitoring
Therapeutic Area(s): Respiratory
Company Status:
Introductions
The Company is ISO 9001 and ISO 13485 (medical devices) approved company and is regularly
audited by LNE (GMED), a European Notified Body, to support these approvals.
Technology & Product(s):
Babysense is the original and first-to-market monitor in its kind. Babysense was developed in
view of the dangers that infants may face in hospitals and at homes associated with sudden
infant death syndrome (commonly known as SIDS and Cot or Crib Death).
Babysense monitor is highly effective and has helped protecting over 1,000,000 babies from
SIDS around the world. It provides a vital measure of protection, which, when combined with
safe sleeping precautions provides safety and peace of mind.
Contents
Babysense is a highly sensitive non-touch baby Breathing Movement Monitor intended for
detection of respiratory distress and cessation (apnea) in babies. It constantly monitors baby's
breathing micro movements through the mattress during baby’s sleep and gives an alert to
caretakers if breathing stops or becomes irregularly slow, giving critical time to intervene. A
quick response can make the difference between something minor and a critical situation.
Babysense is clinically proven and medically certified. It is approved to the Medical Devices
Directive 93/42/EEC and is listed as Medical Device in Europe, Israel, Australia, Japan, Korea,
etc.
Objectives:
Target Businesses:
Target Countries:
Penetrating Babysense product to the Target Countries
Distributors, Manufacturers, Investors, Strategic Partners
China, India, South Korea, Singapore, Hong-Kong
Profiles
Goals:
8
www.syrolight.com
Company at a Glance:
BioLight is the producer of electronic phototherapy devices, based on low level narrow band
red light. Our devices offer non-invasive, drug-free, side-effect-free treatment for: hay fever,
oral lesions, chronic pain and rheumatoid arthritis as well as acne and chronic wounds.
BioLight recently developed the new BioNette, a sophisticated second generation of the
original BioNase that very effectively treats hay fever (allergy rhinitis).
Welcome
BioLight Medical Devices
Allergic rhinitis is a 21st century disease unknown before the 18th century. Researchers
predict that within 20 years 50% of western population will suffer from it (today it is estimated
that approx. 20%-25% of the population suffers from allergic rhinitis).
Introductions
Due to the BioNette’s unique design and technology, it has already been chosen by some of
the world's largest retailers and distributors including:
• Boots (UK), the largest health and beauty chain in the world,
• Sinopharm (China), the largest pharmaceutical conglomerate in China,
• Hanmi Medicare (Korea), the second largest pharmaceutical conglomerate in Korea,
• Wholesale Medical Network (WMNI, Canada), a very respected wholesaler in Canada
• MarpelPharma (Mexico), a leading pharmaceutical distributor
• Gala Optics (Russia) a leading medical distributor
• Colombia (Neuropharma) a nationwide drug distributor
• Imir Kimya (Turkey)
• Retia (Slovakia)
Category, Sub-category & Therapeutic Area(s):
Medical Devices
Medical Equipment
Allergy, Ear Nose &Throat (ENT)
Initial Revenues
Technology & Product(s):
BioLights’ other products are:
• BioStick - a personal device for treating aphthas, gingivitis, cold sores, etc.
• BioBeam 660 - for treating acne and non-healing wounds
• BioBeam 940 - for relieving rheumatic arthritis pains
Goals:
BioLight is looking for reputable distributors and wholesalers to
collaborate in the selling and marketing of the BioNette
BioLight is represented in China exclusively by Sinopharm Group
and will collaborate with Sinopharm in order to reach out for regional
distributers
Medical devices distributors, wholesalers and investors
APAC, Americas, Europe
Profiles
Objectives:
Target businesses:
Target Countries:
Contents
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
9
C
N GA
M E D I C A L
Seeing Beyond Imagination
www.cnoga.com Company at a Glance:
Cnoga Medical develops innovative Non Invasive medical devices for Diabetes & Cardiovascular
disease. Using a camera image sensor and unique patent algorithm Cnoga medical manage
to analyze the vast amount of data to compute desired Bio Parameters and perform Blood
Chemistry analysis.
Welcome
Cnoga Medical Ltd.
• The TensorTip Non Invasive Combo Glucometer
Non Invasive Blood Glucose Meter, needle-free and portable device for Diabetic patients.
Cnoga’s Patented algorithms and unique technology transform the current blood glucose
test to a painless and easy procedure. Based on a personal calibration the CoG provides
diabetic patients with an accurate Non invasive solution to measure blood glucose.
• The TensorTip Matrix (MTX)
A Small Noninvasive Monitoring device measuring various Bio parameters, Hemodynamic
& Blood Gas parameters.
• Parameters: Hemoglobin, Hematocrit Blood Pressure, Pulse, Oxygen saturation, Cardiac
Output MAP, SV, PO2 , PCO2, Heart and Pulse Waveform, Blood Pressure Waveform.
• Regulatory Status:
Cnoga Medical received the CE mark for its Non Invasive Combo Glucometer, VSM and MTX.
Cnoga Medical received FDA approval for the Blood pressure and Pulse (VSM).
Introductions
• The TensorTip Vital Sign Monitor (VSM)
A Small Non Invasive Monitoring device measuring continuous Blood Pressure without
arm cuff, Pulse and Spo2.
Category, Sub-category & Therapeutic Area(s):
Medical Devices
Diagnostic, Telemedicine, Monitoring
Diabetes, Endocrinology, Cardiovascular
Initial Revenues
Technology & Product(s):
Non Invasive Combo Glucometer The TensorTip Combo Glucometer (CoG) is a noninvasive, needle-free and portable device.
Contents
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Cnoga’s unique technology transforms the current blood glucose test to a painless and
easy procedure. Based on a personal calibration. Cnoga medical non invasive glucometer is
currently the only commercially available non invasive solution that complies with the accuracy
standard of the traditional invasive brand.
Objectives:
Target Businesses:
Target Countries:
Searching for medical distributors
Distributors
South America , Europe and Asia
Profiles
Goals:
10
www.easynotes-medical.com
Company at a Glance:
EasyNOTES, established in 2011, is a privately held medical device company located in Israel.
EasyNOTES’s mission is to provide an endoscopic solution for diabetes control and to solve
an unmet need of 380 million diabetics worldwide. In 3 years of extensive research, efficacy
of treatment for Type 2 Diabetes was proven in animal models. With clinical products in
production the company is preparing for its first clinical trial
Welcome
‫‏‬EasyNotes Medical Ltd.
Category, Sub-category & Therapeutic Area(s):
Medical Devices
MIS - Minimally Invasive System
Diabetes, Metabolic Surgery
Clinical trials
Technology & Product(s):
Goals:
Objectives:
Target Businesses:
Target Countries:
To establish relations with strategic partner that will be able to take
the system to the market
Investors, Strategic Partners
China, India, Japan, Singapore, Hong-Kong
Contents
Type 2 Diabetes is a 21st century epidemic, affecting 1 in 10 adults. Patients must self-monitor
and medicate multiple times a day to control glucose levels. The success rate in controlling
the disease is less than 60% and to date, no remission method is available. Recently, gastric
bypass surgery in obese Type 2 Diabetics was shown as a method to cause remission or
improvement of the disease. The drawback is that obesity procedures are considered a
major, irreversible, high cost surgery aimed at weight loss and not diabetes. EasyNOTES
offers a technique which takes the element of bariatric surgery that treats Type 2 Diabetes
and perform it with an endoscope, thus creating a simple, non-surgical procedure which
is performed in the GI suite, has lower the risk of complications, minimizes inconvenience
to the patient, eliminates the need for hospitalization and uses lower-cost resources. The
procedure is performed using the paten protected EasyByPass (EBP) system, developed and
produced by the company. The EBP system includes magnetic system to create a path for
food to bypass the duodenum and special plug to close the pylorus.
Introductions
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Profiles
11
www.icecure-medical.com
Company at a Glance:
IceCure Medical is an Israeli company that develops and markets minimally invasive cryoablation
therapies for women’s health and other areas. Our proprietary IceSense3™ system provides
minimally invasive, in-office definitive treatment for breast tumors, both benign and breast
cancer (1).
Welcome
IceCure Medical Ltd.
IceCure sells its products in the U.S (both direct and by distributors through its subsidiary
IceCure Medical, Inc. having its office in Memphis, Tennessee. Among our U.S clients are breast
centers in reputable institutions as well as private clinics operated by breast surgeons and
radiologists. In other geographies, IceCure uses specialized distributors that provide clinical
and technical sales support in Asia and Europe.
Thanks to its unique and innovative technology, IceCure participate in several clinical studies
for treatment of other indications such as lung cancer, Kidney cancer and breast cancer. The
company also develops a product for treating uterine fibroids.
With the global trend of taking procedures from the operating room to the office environment
and decreasing their costs, IceCure’s innovation brings the future to the present!
Under clinical studies in the U.S and Japan
(1)
Category, Sub-category & Therapeutic Area(s):
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Medical Devices
MIS - Minimally Invasive System
Women's Health, Oncology
Initial Revenues
Cryoblation is a minimally-invasive ultrasound /CT guided treatment that uses extreme cold
to freeze and accurately destroy diseased tissue within the tumor zone. The ablated tumor
becomes necrotic and as such, shrinks and is absorbed by the immune system. Cryoablation
exists for more than 2 decades and has been successfully used in various application based
on slow, gas-based technology. IceCure uses liquid-Nitrogen based technology which is more
compact, faster and more efficient.
IceCure sells the IceSense3™ system in the U.S since mid-2011 for the treatment of benign
breast tumors under CPT code 19105, with support of the American Society of Breast Surgeons
(ASBS). Recently, clinical results from a study of treatment of small breast cancer tumors were
published, showing no cancer recurrence after follow-up period of up to 6 years. IceCure
intends to continue with more U.S and international studies in this promising direction.
Objectives:
Target Businesses:
Target Countries:
Expand sales in the U.S and other countries, use platform to enter
new areas
Women’s health, interventional oncology, general surgery
On top of the U.S and Europe: China, India, Latin America
Profiles
The procedure is a safe and effective treatment option that has the following characteristics:
• Performed by one physician
• An office procedure
• Local anesthesia
• Can be completed in 5-15 minutes
• No pain
• No scar, superior cosmetic results
• Short recovery time
• Promising treatment for small breast cancer tumors(1)
(1)
Under clinical studies in the U.S and Japan
Contents
Technology & Product(s):
Goals:
Introductions
IceCure has FDA and CE approval for broad benign and malignant indications. The company
is also in advanced regulatory process in China with the CFDA as well as other Asian and
South American countries.
12
www.levhm.com
Company at a Glance:
Lev El Diagnostics of Heart Diseases Ltd. (Lev El), is a privately-held biomedical company that
specializes in the detection of cardiovascular diseases.
Our flagship product, HeartTrends™, is a diagnostic software tool for the detection of
myocardial ischemia related to Coronary Artery Disease (CAD) at its early stage, and is used
for screening between sick and healthy individuals. HeartTrends offers an alternative to the
standard Exercise Stress Test (EST) with its significantly improved outcomes including superior
sensitivity (77%) and high negative predictive value (98%).
Welcome
LevEL Diagnostics of Heart Diseases
Category, Sub-category & Therapeutic Area(s):
Medical Devices, Healthcare IT
Diagnostic, Telemedicine
Cardiovascular, General Health
Initial Revenues
Technology & Product(s):
Many millions of annual exercise stress tests are done worldwide at public and private
hospitals (in & out patients), Cardiology clinics, General Practitioners , Health checkup centers
Corporations (tests for employees), Sports unions and Gyms, National Health Insurance,
Health insurance companies (health assessments). Exercise stress Test (EST) is the most
routine screening test for Myocardial Ischemia, however it's unreliable. Misdiagnosis will have
a significant impact on patient's outcomes and could result in harm and unnecessary costs.
This is what the HeartTrends is addressing.
The opportunity with HeartTrends™ is to replace EST’s for the general population in addition
to being an ideal solution for 30% of the population that cannot undertake EST’s (e.g.
handicapped, elderly, obese and even athletes who cannot reach their target pace during a
standard EST).
Competitive Edge:
Goals:
Objectives:
Target Businesses:
Target Countries:
To accomplish successful business activity
Distributors, strategic partners, KOL’s
Asia
Profiles
• From the end user perspective the HeartTrends is a reliable, simple, quick, easy to use, no
stress involved test. Test can be done at the doctor’s clinic, or even at patients’ home or
office.
• Done at rest – patient can sit, walk, talk, etc.
• An ideal solution for 30% of the population who are unsuitable for EST
• From the physician’s (customer) perspective the HeartTrends test is highly reliable compared
to exercise stress test, no expensive and bulky equipment required, and patients are not
exposed to the unnecessary risk of exercise, radiation or to an invasive/semi invasive
procedure.
• HeartTrends was proved to be very effective in terms of time & motions analysis.
• No need for a doctor to be present during the test
• Scalable – multiple tests done simultaneously
• Progressive business mode (PPU)
Contents
The HeartTrends™ test is done at rest by analyzing a simple standard one-hour ECG Holter
data recording for the purpose of detecting myocardial ischemia. There is no need for a doctor
to be present during the test and since the test is done at rest, there is no risk to the patient.
Introductions
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
13
Non Invasive Thermometry
www.medisim.co.il
Company at a Glance:
Medisim Ltd. Is a privately held company which develops and manufactures patented diagnostic
medical devices for home and professional use.
Medisim Ltd. has a reputation for its quality and innovative top class thermometry products
and for its know-how of core body temperature establishment.
Welcome
Medisim Ltd.
Inspired by parents' needs, relying on state-of-the-art technology and extensive R&D, Medisim's
thermometers offer accurate and reliable readouts, easy to use interface and unique design.
Medisim's thermometers are successfully being sold in the United States, Europe and Australia
and can be found broadly in large national chains.
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Medical Devices
Diagnostic
General Health
Revenue Growth
Technology & Product(s):
Medisim's line of home-use thermometers is based on the patented R.A.T.E technology; Utilizing
a unique sensor, R.A.T.E rapidly samples the heat flowing from the blood vessels to the skin
surface and accurately translates it to the core body temperature.
Introductions
Category, Sub-category & Therapeutic Area(s):
Medisim's thermometers enable fast and reliable non-invasive measurement in the temple
area of the forehead, easy to use interface and unique design.
Mini Temple Touch - digital thermometer
Mother's Touch - digital thermometer
Goals:
Objectives:
Target Businesses:
Target Countries:
Partner with major national players within the OTC and the babies
market
OTC market: Pharmacy chains, Drugstore chains, Babies & Kids market,
Distributors to these markets
China
Profiles
Using the intuitive gesture of touching your child’s forehead when suspecting a fever, we
offer a thermometer that’s as gentle as a Mother’s Touch.
Key Features:
• Innovative, baby friendly design
• Non-invasive measurement -awake or asleep
• Fast and accurate results; 4-6 seconds readout
• Large display
• Simple one button operation
• Last reading memory
• Fever alert
• Room temperature
Contents
Non-invasive temple measurement - awake or asleep
Key Features:
• Fast & accurate results; 4-6 seconds readout
• Gentle, flexible probe
• Large display
• Easy to use one button operation
• Last reading memory
14
www.meditouch.co.il/en
Company at a Glance:
Physical Rehabilitation assistive technology
MediTouch, formed in 2004, is a successful and vibrant Israeli company that develops and
manufactures assisted technology solutions for physical and occupational rehabilitation. Our
innovative solution improves patient movement ability and quality of life following neurological
and orthopedic injury and disease, including post stroke, spinal cord and brain injury, MS,
Parkinson’s disease, nerve injury and total knee and hip surgery. The Tutor system is used
worldwide in major rehabilitation clinics and by patients at home.
Patients with upper and lower limb movement dysfunction use our system in order to practice
customized exercise practice according to their movement ability within a motivating and
challenging environment.
This ensures that the patient undertakes intensive and repetitive practice which is the
fundamental of manual therapy and modern physical rehabilitation.
MediTouch's products include ergonomic wearable biomechanical biofeedback systems, active
and passive training systems, a robotic dynamic balance trainer system, BalanceTutor, and
dedicated rehabilitation and tele- rehabilitation software.
Category, Sub-category & Therapeutic Area(s):
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Medical Devices, Services
Medical Equipment, Monitoring, Telemedicine
Neurology & Degenerative Disease, Orthopedic, Pediatrics, Rehabilitation
Revenue Growth
Contents
Our rehabilitation system is used in many clinics worldwide including Germany, USA, China
and by home care patients. Home care patients receive online tele-rehabilitation support
from occupational and physical therapists and physiotherapists and this contributes to their
improved rehabilitation outcome.
Introductions
The MediTouch solution consists of motion capture gloves and braces including the HandTutor,
ArmTutor, LegTutor and 3DTutor. Together with dedicated rehabilitation software the solution
provides physical and occupational therapists with high technology therapy tools for fine
and gross motor rehabilitation.
Welcome
MediTouch
Technology & Product(s):
Motion-capture gloves and braces for the upper and lower extremity including the HandTutor,
ArmTutor, LegTutor and 3DTutor. The devices use electro optical sensors and accelerometers.
The MediTouch systems use motion feedback that allows further customizing the exercise task
to the patients’ sensory motor and cognitive movement ability. MediTouch has also introduced a
robotic dynamic balance trainer system, BalanceTutor that uses the proven principle of perturbation.
All systems provide capture and recording of the quantitative data concerning the rehabilitation
process and allow objective follow up to ensure therapy accountability.
Goals:
Objectives:
Profiles
Dedicated MediTutor rehabilitation software for treatment and evaluation and home exercise
monitoring.
Increasing worldwide distributor network, Establishing direct relationship
with health care systems
15
www.ps-med.com
Company at a Glance:
Persys Medical Group is a global organization which manufactures, markets and distributes
innovative lifesaving medical devices for Military, EMS's, Law Enforcement, Disaster Preparedness,
Search and Rescue, pre-hospital and in-hospital use.
Among our brands:
Welcome
PerSys Medical
• The Emergency Bandage
• Blizzard Thermal Protection
• B.I.G. – Bone Injection Gun
Category, Sub-category & Therapeutic Area(s):
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Medical Devices
Medical Equipment, Drug Delivery
Emergency Medicine
Revenue Growth
Technology & Product(s):
The Emergency Bandage – (AKA the Israeli Bandage®) All-in-one bandage, consolidates multiple
first-aid devices: a primary dressing, pressure applicator, secondary dressing and a foolproof
closure bar to secure the bandage in place. The bandage is easy to use, appears in several
sizes and different colors, used by militaries and civilian arenas worldwide.
Blizzard's unique Reflexcell™ technology provides thermal protection, maximum warmth,
reduces symptoms of shock, and guards against the risk of hypothermia and its associated
complications. Supports Hypothermic patient treatment and increases survival rates in extreme
conditions.
Contents
The B.I.G. Bone Injection Gun & The NIO New Intra Osseous device – used by military and
civilian healthcare systems worldwide. These – are small, light, and easy to use, automatic
intra-osseous devices which allow quick and safe access to the patient's vascular system
within 10 seconds for fluid and drug administration.
Introductions
• NIO – New Intraosseous device
Goals:
Objectives:
Looking for reputable distributors and wholesalers for our products
Target Businesses: EMS's, Law Enforcement, Military, Disaster Preparedness, Search and
Rescue, pre-hospital and in-hospital
Target Countries: Worldwide
Profiles
16
healthcarescales.com
Company at a Glance:
Shekel Scales Ltd., established in 1977, is a worldwide leader in the design and manufacture
of electronic scales, advance weighing systems, and force measurement applications. Since
its inception, Shekel has grown steadily to establish its position as a significant innovation
leader in the market. Shekel's outstanding combination of sophisticated software and core
weighing engineering technology enables the company to offer creative solutions for a wide
range of OEM weighing needs. Shekel implements strict quality control management to ensure
the highest standards of its products.
Shekel Scales headquarters are situated in Israel. Shekel (Ningbo) Scales factory, established
in 2011 as a wholly owned subsidiary, serves as a production facility for Shekel products.
The company also has an office in the US.
Category, Sub-category & Therapeutic Area(s):
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Medical Devices, Healthcare IT, Others (Industrial use / OEM)
Medical Equipment, Telemedicine, EHR, Hospital Units/Clinics, SW
and HW
General Health
Revenue Growth
Introductions
Shekel's Healthweigh® line is a top tier line of digital electronic professional medical scales. The
Healthweigh® products yield very high precision results, and are designed to be user friendly.
Shekel's systems were the first in the world to be integrated into warmers and incubators
used to sustain premature babies.
Welcome
Shekel Scales Ltd.
Technology & Product(s):
Healthweigh® Physician Scales provide a reliable weighing system for medical centers, clinics,
hospitals, fitness centers and the home.
Contents
Shekel Healthweigh® offers a wide range of high quality digital healthcare scales with
unique innovative designs. All scales connect to EHR systems so weighing information can
be communicated to the patient's medical records. Advanced movement compensation
technology eliminates involuntary movement made during the weighing process and ensures
exact weighing information.
Healthweigh® Special Needs scales respond to the needs of diverse medical sectors. This range is
extremely user oriented, comfortable, easy to use and operate, and most importantly – perfectly safe.
Healthweigh® Neonatal Scale is ergonomically designed for the newborn and growing baby.
All scales are OIML approved.
Objectives:
Target Businesses:
Target Countries:
To reach new business partners and distributors
Hospitals and Medical Clinics
Global
Profiles
Goals:
17
www.simbionix.com
‫‏‬Company at a Glance:
For nearly two decades 3D Systems® has pioneered healthcare solutions that enhance
quality of life through the use of 3D printing technologies. Today we are manufacturing the
future of Healthcare with a commitment to innovation that will propel medical research and
treatment forward with offerings that include training and surgical simulation, reconstruction
tools, personalized surgery technologies, 3D printing-centric tools and medical contract
manufacturing services.
Category, Sub-category & Therapeutic Area(s):
Category:
Medical Devices
Sub-category:
Training
Therapeutic Area(s): Cardiovascular, Dental, Emergency Medicine, Gastrointestinal, General
Surgery, Gynecology, Internal Medicine, Obesity, Obstetrics, Oral Care,
Orthopedic, Prenatal, Primary Care, Pulmonary, Respiratory, Urology,
Women’s Health
Company Status:
Revenue Growth
Introductions
3DS offers the broadest array of healthcare solutions designed to meet the needs of
customers ranging from medical device OEMs and teaching hospitals to individual healthcare
professionals. These technologies are available for integration with existing products or to
enable the creation of wholly new treatment methodologies.
Welcome
3D Systems - Simbionix Products
Technology & Product(s):
The 3D Systems’ Simbionix product line pioneered virtual reality medical simulation. The
medical simulators combined with 3D printed anatomical phantoms offer clinicians the most
realistic hands-on experience in medical and surgical training without patient risk.
3D Systems’ PROcedure Rehearsal Studio™ assists clinicians as they prepare for an upcoming
procedure by creating a patient specific 3D anatomical model based on scanned images.
The segmentation files can be exported to a virtual simulated environment, or physically printed
by 3D printers, to simulate, analyze and evaluate pre-operative surgical treatment options.
Goals:
Target Businesses:
Target Countries:
To familiarize the local market with our products and services and
create business relationships
Training Centers, Hospitals
APAC
Profiles
Objectives:
Contents
Backed by over 200 clinical validations, the simulators span all disciplines with a depth of tasks
and procedures unmatched in the industry. High quality, technologically advanced products
are developed with physicians and medical societies to provide surgeons, interventionists,
nurses and technicians with a comprehensive platform to learn and master critical skills to
ensure procedural efficiency and promote quality outcomes.
18
www.sonicbonemedical.com
Company at a Glance:
It is estimated that about 10% of the world's children population under the age of 18 are at
risk of suffering from growth and maturation disorders and consequently may need clinical
follow-up or endocrine treatments.
SonicBone Medical, a privately held medical device company based in Israel, has developed
with collaboration of Pediatric Endocrinologists, a next-generation ultrasound diagnostic
system - BAUS™, for performing skeletal maturity or Bone Age assessment (BA), which is a
common medical procedure that has an important role in children and adolescents' healthcare.
BAUS™ is used in Pediatrics, Pediatric Endocrinology, Orthopedics and Orthodontists, in Legal
Medicine and in Sports (for final adult height prediction).
SonicBone's novel solution was designed to replace current bone age assessment method
on the market, which is based on interpretation of X-ray images and carry major deficiencies.
BAUS™ addresses a significant globally unmet clinical need, improving the diagnosis of
children's growth disorders, treatment and follow up, thus enabling better healthcare services
for children and substantial savings to healthcare providers, especially in the developing
countries and the underserved communities.
Introductions
BA is used for evaluating growth and puberty related endocrine disorders, secondary to
hormonal or metabolic functions, such as: Growth hormone deficiency, precocious puberty,
bone diseases, chronic diseases, Genetic growth disorders, etc.
Welcome
SonicBone Medical Ltd.
Category, Sub-category & Therapeutic Area(s):
Medical Devices
Diagnostic
Pediatrics, Endocrinology, Primary Care
Regulatory Approval, Initial Revenues
Technology & Product(s):
BAUS™ is a novel revolutionary ultrasound-based solution. It is safe, non-invasive and radiation
free unlike the current BA methods where Biohazard radiation is emitted on children through
the X-ray examination, especially when children patients might need several X-rays per year
for the duration of several years.
Contents
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
BAUS™ results are digital with reference to the various population norms worldwide and
have a better precision rate than the current methods; readings are objective and nonoperator-dependent.
BAUS™ is simple to use and no special training is required for its operation
BAUS™ is cost-effective and is available for purchase in two ways: Capital sale and PayPer-Scan model
Goals:
Objectives:
Target Businesses:
Target Countries:
To establish new distribution and strategic collaborations channels
Distributors, Investors, Strategic Partners
China, India, Japan, South Korea, Singapore, Hong-Kong
Profiles
BAUS™ is portable and can be placed at doctor’s office setting, enabling clinical follow up on
children under treatment to examine effectiveness of medication. It enables for the first time
ever, treatments and research activities in Pediatric Endocrinology in remote areas where
x-ray facilities are scarce or not available.
19
www.sti-laser.com
Company at a Glance:
STI Laser Industries Ltd. is a privately owned contract manufacturer of medical devices,
specializing in laser cutting, micromachining and finishing of miniature metal components.
We focus on manufacturing of implants – stents, heart valves and orthopedic devices, as
well as on special surgical tools used in minimally invasive surgery.
Welcome
STI Laser Industries Ltd.
STI provides a comprehensive manufacturing platform for medical device, bio-engineering
and hi-tech companies seeking prototyping, small series or contract manufacturing services.
STI supports customers through the life cycle of their products, providing the engineering and
manufacturing solutions required to successfully develop and manufacture their products.
• Micro machining of metal components, including: laser processing, heat treatment and
surface treatments;
• Contract manufacturing of medical implants and surgical tools, intended for minimal invasive
surgery, aesthetic surgical procedures, dental implants;
• Assembly and packaging of medical devices and components in a controlled environment
area.
Category, Sub-category & Therapeutic Area(s):
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
Medical Devices
Disposable & Implantable, MIS - Minimally Invasive Systems
Cardiovascular, Gastrointestinal, Orthopaedic
Revenue Growth
Introductions
STI specializes in processing implantable biocompatible metals, including shape-memory
alloy – Nitinol. The company is certified to EN ISO 13485 and ISO 9001, with the following
scope of services:
Technology & Product(s):
Objectives:
Target Businesses:
Target Countries:
To become the chosen manufacturing partner of medical device
companies
Developers of medical devices, established medical device companies
USA, South America, Europe, Japan, China, South Korea, Vietnam, Singapore
Profiles
Goals:
Contents
STI offers a comprehensive Manufacturing Platform For Medical Devices, including:
• Laser Cutting – of tubes - Stainless Steel, Cobalt Chrome and Nitinol, with OD from 0.50mm
to 40mm. Auto-focus laser cutting of sheets of up to 2mm thick with ±5 micron accuracy.
• Laser Welding – of metals: spot welding with minimal heat affected zone (radio-opaque
markers) and seam welding.
• Heat Treatments – annealing and shape-setting of Nitinol, operating both vacuum and
alumina furnaces.
• Surface Treatments – mechanical treatments (sand blasting, tromel), electro-polish and
passivation.
• Clean Room Services – complete turn-key product assembling, testing and packaging in
Class 10,000.
• Quality Assurance (QA) – shifts the importance from quality inspection at the end of
production towards responsible quality control throughout every aspect of production,
thereby building quality assurance procedures into the process itself. In-house testing
capabilities including radial force testing, tensile testing, advanced FOV measurement
equipment.
• Engineering - STI teams up with bio-engineers and mechanical engineers having a proven
design track record of a wide variety of medical implants and surgical tools. STI helps its
customers select the engineer that can offer the most relevant expertise to the customer’s
specific needs.
• Additional services – Finite Element Analysis, SEM scanning, bench tests and protocols for
submission to regulatory bodies (CE and FDA).
20
www.tav-tech.com
Company at a Glance:
TavTech – A Fresh New Perspective
TavTech Ltd. is a privately-owned company, based in Israel, with a mission to continuously
develop medical and aesthetic applications based on its unique Jet Technology.
Welcome
Tavtech Ltd.
Since its establishment TavTech has been developing and delivering state-of-the-art medical
and aesthetic devices and applications that are changing the way non-invasive treatments
are carried out today.
The company products are manufactured in a GMP-compliant facility, using TavTech proprietary
molds and assembly tools. TavTech is also approved to ISO 13485 (including CMDCAS for
Canada) and to ISO 9001. TavTech's medical products are CE Marked in accordance with
the EU's Medical Devices Directive (93/42/EEC), while its aesthetics-care products are CE
Marked according to the appropriate directives.
TavTech Ltd. owns worldwide patents covering well all the devices and systems developed by
the company for providing a pressurized gas-liquid flow suitable for medical and cosmetic
applications, among others.
Introductions
In recent years TavTech's major shareholder is Bioville, owned by the Mayer family who
conducting intense activities in the real estate markets in the US, Swiss and Israel; Bioville
carries wide portfolio of investments in bio medical companies.
TavTech devices and operation methods are simple to operate and can deliver a variety of
substances such as vitamins, nutrients and minerals into the skin non-invasively, keeping the
whole process painless and clean.
Category, Sub-category & Therapeutic Area(s):
Medical Devices
Drug delivery, MIS - Minimally Invasive System
Dermatology and Aesthetics, Gastrointestinal, Wound management
Revenue Growth
Technology & Product(s):
Goals:
Objectives:
Target Businesses:
Target Countries:
Distributors, Direct Customers
Aesthetic Dermatology Departments, Aesthetic Clinics
China, Taiwan, Hong Kong
Profiles
TavTech's patented technology is today successfully applied in aesthetic skin rejuvenation,
wound management, gastrointestinal (colonoscopy) and surgery. TavTech is extending its
technology to additional segments within the medical and aesthetic spectrum, such as scalp
and hair care etc; and there is more to come. The company's technological principle is simple,
though sophisticated; liquids, e.g. saline, vitamins, acids, etc. are accelerated using pressurized
air to high velocities by means of a unique handpiece-nozzle that breaks the accelerated liquid
into micro-droplets. This stream of micro-droplets can be used either for medical applications
or for aesthetics-care and a variety of skin conditions applications.
Contents
Category:
Sub-category:
Therapeutic Area(s):
Company Status:
21
Welcome
Introductions
Contents
a t C M E F 2 01 5
© April 2015 • The Israel Export & International Cooperation Institute
Production: IEICI Media & Communication Division • Design: Studio Billet
Profiles
This publication is for informational purposes only. While every effort has been made to ensure
the information is correct, The Israel Export & International Cooperation Institute assumes
no responsibility for damages, financial or otherwise, caused by the information herein.